Keith A. Dookeran

533 total citations
39 papers, 370 citations indexed

About

Keith A. Dookeran is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Keith A. Dookeran has authored 39 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 15 papers in Cancer Research and 8 papers in Genetics. Recurrent topics in Keith A. Dookeran's work include Breast Cancer Treatment Studies (10 papers), Global Cancer Incidence and Screening (8 papers) and Cancer Diagnosis and Treatment (5 papers). Keith A. Dookeran is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Global Cancer Incidence and Screening (8 papers) and Cancer Diagnosis and Treatment (5 papers). Keith A. Dookeran collaborates with scholars based in United States, United Kingdom and Nepal. Keith A. Dookeran's co-authors include Malcolm J. Underwood, Peter Bell, R.D. Sayers, Matt Thompson, David Lloyd, M M Thompson, Marin Sekosan, Worta McCaskill‐Stevens, Karen Ferrer and James J. Dignam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Keith A. Dookeran

38 papers receiving 348 citations

Peers

Keith A. Dookeran
Michael J. Higgs United Kingdom
Keith Sultan United States
Brenda K. Shelton United States
Andrea N. Riner United States
Alexis Zebrowski United States
Rima Patel United States
Elizabeth Smyth United Kingdom
Aditi Anand United States
Michael J. Higgs United Kingdom
Keith A. Dookeran
Citations per year, relative to Keith A. Dookeran Keith A. Dookeran (= 1×) peers Michael J. Higgs

Countries citing papers authored by Keith A. Dookeran

Since Specialization
Citations

This map shows the geographic impact of Keith A. Dookeran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith A. Dookeran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith A. Dookeran more than expected).

Fields of papers citing papers by Keith A. Dookeran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith A. Dookeran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith A. Dookeran. The network helps show where Keith A. Dookeran may publish in the future.

Co-authorship network of co-authors of Keith A. Dookeran

This figure shows the co-authorship network connecting the top 25 collaborators of Keith A. Dookeran. A scholar is included among the top collaborators of Keith A. Dookeran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith A. Dookeran. Keith A. Dookeran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Janine Y., et al.. (2024). Feasibility of clinical newborn metabolic screening in a high-volume maternity center in Nepal. SHILAP Revista de lepidopterología. 2(1). 10–10. 2 indexed citations
2.
Bakulski, Kelly M., et al.. (2024). Racialized experience, biomarkers of lead exposure, and later-life cognition: a mediation analysis. American Journal of Epidemiology. 194(2). 420–431. 2 indexed citations
3.
Dookeran, Keith A., et al.. (2023). Disparity in neonatal abstinence syndrome by race/ethnicity, socioeconomic status, and geography, in neonates ≥ 35 weeks gestational age. PLoS ONE. 18(4). e0284040–e0284040. 1 indexed citations
4.
Dookeran, Keith A., et al.. (2021). An assessment of prevalence and expenditure associated with discharge brain MRI in preterm infants. PLoS ONE. 16(3). e0247857–e0247857. 2 indexed citations
5.
Dookeran, Keith A., Wei Zhang, Leslie Stayner, & Maria Argos. (2017). Associations of two-pore domain potassium channels and triple negative breast cancer subtype in The Cancer Genome Atlas: systematic evaluation of gene expression and methylation. BMC Research Notes. 10(1). 475–475. 19 indexed citations
6.
Dookeran, Keith A., et al.. (2017). The Emerging Role of Two-Pore Domain Potassium Channels in Breast Cancer. UWM Digital Commons (University of Wisconsin–Milwaukee). 27–36. 3 indexed citations
7.
Smith, Caren E., Stephanie M. Fullerton, Keith A. Dookeran, et al.. (2016). Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities. Health Affairs. 35(8). 1367–1373. 65 indexed citations
8.
Dookeran, Keith A., et al.. (2016). Clinical Outcomes Associated with a Failed Infant Car Seat Challenge. The Journal of Pediatrics. 180. 130–134. 7 indexed citations
9.
Dookeran, Keith A., Abigail Silva, Richard B. Warnecke, & Garth H. Rauscher. (2014). Race/Ethnicity and Disparities in Mastectomy Practice in the Breast Cancer Care in Chicago Study. Annals of Surgical Oncology. 22(1). 66–74. 16 indexed citations
10.
Dookeran, Keith A., James J. Dignam, Karen Ferrer, et al.. (2012). Race and the Prognostic Influence of p53 in Women with Breast Cancer. Annals of Surgical Oncology. 19(7). 2334–2344. 9 indexed citations
11.
Dookeran, Keith A., James J. Dignam, Karen Ferrer, et al.. (2010). p53 as a Marker of Prognosis in African-American Women with Breast Cancer. Annals of Surgical Oncology. 17(5). 1398–1405. 43 indexed citations
12.
Dookeran, Keith A.. (2008). Factors Associated with Advanced Disease Stage at Diagnosis in a Population-based Study of Patients with Newly Diagnosed Breast Cancer. Breast Diseases A Year Book Quarterly. 19(3). 242–243. 1 indexed citations
13.
Dookeran, Keith A., Yu Wang, Karen Ferrer, et al.. (2007). Basal subtype predicts poorer prognosis in younger, but not older, African-American women with breast cancer.. Cancer Research. 67. 2510–2510. 2 indexed citations
14.
Dookeran, Keith A.. (2007). The Roles of Teaching Hospitals, Insurance Status, and Race/Ethnicity in Receipt of Adjuvant Therapy for Regional-Stage Breast Cancer in Florida. Breast Diseases A Year Book Quarterly. 17(4). 339–339. 1 indexed citations
15.
Dookeran, Keith A., Yiting Wang, Karen Ferrer, et al.. (2006). p53 status is more likely than basal subtype to predict survival in African-American women with breast cancer. Clinical Cancer Research. 12. 1 indexed citations
18.
Wilkins, David C. & Keith A. Dookeran. (1997). Audit of general practitioner referrals to a surgical assessment unit: New methods to improve the efficiency of the acute surgical service. British journal of surgery. 84(5). 727–728. 2 indexed citations
19.
Rye, Philip D., et al.. (1993). Expression Of The Ps2 Peptide In Normal Human Glandular Endometrium During The Menstrual Cycle: A Possible Function. Disease Markers. 11(1). 23–28. 2 indexed citations
20.
Dookeran, Keith A., Philip D. Rye, Sheila J. Dearing, & R A Walker. (1993). Expression of the pS2 peptide in primary breast carcinomas: Comparison of membrane and cytoplasmic staining patterns. The Journal of Pathology. 171(2). 123–129. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026